EP0586789B1 - Gleichmässig verteilte Anreicherung einer in Lösung vorliegenden Substanz auf der feinporigen Seite einer asymmetrisch porösen Membran - Google Patents
Gleichmässig verteilte Anreicherung einer in Lösung vorliegenden Substanz auf der feinporigen Seite einer asymmetrisch porösen Membran Download PDFInfo
- Publication number
- EP0586789B1 EP0586789B1 EP93105630A EP93105630A EP0586789B1 EP 0586789 B1 EP0586789 B1 EP 0586789B1 EP 93105630 A EP93105630 A EP 93105630A EP 93105630 A EP93105630 A EP 93105630A EP 0586789 B1 EP0586789 B1 EP 0586789B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- membrane
- substance
- solution
- porous membrane
- fine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/525—Multi-layer analytical elements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/34—Purifying; Cleaning
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0825—Test strips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0887—Laminated structure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/08—Regulating or influencing the flow resistance
- B01L2400/084—Passive control of flow resistance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4005—Concentrating samples by transferring a selected component through a membrane
- G01N2001/4016—Concentrating samples by transferring a selected component through a membrane being a selective membrane, e.g. dialysis or osmosis
Definitions
- the invention relates to the use of asymmetrically porous membranes in analytical processes and test carriers for implementation such procedures.
- Such solid analysis media are used as test carriers, above all in the form of flat strips or platelets, which for Investigations, especially of biological liquids, such as blood, plasma, serum, urine etc., carry the required reagents.
- the carrier materials themselves are solid and contained in usually also the reagents in solid form.
- carrier materials are, for example, fibrous structures, such as paper, Nonwovens, fabrics, knitted fabrics, nets etc., in the to be examined Liquid swellable or soluble films or porous membranes known.
- the one for carrying out the determination of analytes in liquids such as B. required body fluids Reagents can pass through to the support materials Impregnation of appropriate solutions or coating with appropriate reagent-containing spreadable compositions and then drying.
- the carrier materials themselves in their Production with the necessary reagents.
- films or membranes made of pourable Solutions or suspensions are already made the reagents necessary for the determination of an analyte contain.
- test carrier When applying a liquid to be examined to one such a test carrier finds a reaction on or in the test carrier between that to be determined in the sample liquid Analyte and the reagents in the carrier material instead of. The reaction products are determined and form a Measure of the amount of analyte in the sample liquid to be examined.
- U.S. Patent 3,607,093 describes a test carrier for the investigation of biological liquids, the one contains liquid-permeable membrane, which at least in Share a diagnostic reagent in solid form, i.e. H. as contains dry substance.
- the membrane itself should look like this be that at least one surface part for larger ones Particles, such as erythrocytes, is impermeable.
- the membrane with a solution of the for the study of biological Liquids required reagent impregnated and dried.
- EP-A-0 345 781 relates to a test carrier for the investigation of Liquids. It contains an asymmetric-porous membrane, which carries one or more reagents which are in the presence of the produce a detectable substance for the analytes to be determined. To determine an analyte in a liquid, the Sample liquid on the large pore surface of the membrane abandoned while measuring from the fine-pored surface forth.
- the "BTS Asymmetric Membrane by Filtrite (San Diego, California, USA), since cellular blood components are separated here and the reagent / analyte reaction anywhere in the Membrane expires.
- reagents that are used in reaction generate a detectable substance with the analyte to be determined, is important for properties important for the detection laid, for example color, chemiluminescence etc., as long as the reagent in the membrane is sufficiently stable.
- EP-A-0 407 800 is on a test strip for the analysis of Substances directed in biological fluids. It contains an asymmetrically porous membrane, which advantageously is produced from a polymer solution containing 1 to 4% by weight contains an anionic surfactant.
- the membrane carries the for the reagents necessary for the analyte determination.
- the analysis is carried out on the liquid to be examined large-pore side abandoned. The measurement of the reaction products takes place from the fine-pored side of the membrane.
- the invention therefore relates to the use of a asymmetrically porous membrane according to claim 1.
- the invention relates to a method for Determination of a substance according to claim 3.
- a particularly advantageous object of the invention is a as described above, characterized in that is that the substance to be determined is hemoglobin and a test carrier suitable therefor according to claim 8.
- asymmetrically porous is general to the person skilled in the art known and customary (cf. for example EP-A-0 407 800 or EP-A-0 345 781). As a rule, this means one continuously porous polymer film with two opposite Surfaces, the pores of a surface being larger are than that of the opposite surface. According to the invention such asymmetrically porous membranes are preferred, which have an asymmetry factor of more than 10, especially preferably have more than 100. The asymmetry factor gives the ratio of the pore size to the large-pore Surface to the pore size on the fine-pored surface on. Such asymmetrically porous membranes are according to the invention preferably used, in which the pore size on the fine-pored side is 0.003 - 3 ⁇ m.
- Asymmetrically porous membranes are from the prior art known, for example from US Patent 4,774,039; U.S. patent 4,629,563 or also from EP-A-0 345 781. According to this state Asymmetric porous membranes can be used in the art by those skilled in the art be made yourself. Asymmetrical porous membranes are also available for sale, for example the BTS 25 membrane from Memtec Timonium, Maryland, USA, according to the invention proven to be advantageous. It is about a porous polysulfone membrane. For the subject of the invention have also been useful with polyvinylpyrrolidone alloyed polyethersulfone membranes, as described, for example, in EP-A-0 336 483. Such membranes are for example under the designation PS 11 or PS 21 by the company X-Flow B.V. (Enschede, the Netherlands).
- the membrane In order to be usable according to the invention, it must be asymmetrical porous membrane of the liquid that is the substance that is on the fine-pored side is to be enriched, contains, wettable be.
- aqueous liquids like this Body fluids such as blood, plasma, serum, urine, etc. are, the membrane must therefore be sufficiently hydrophilic.
- the membrane material itself is not sufficiently hydrophilic polymer membranes can also be hydrophilized. For this can treat membranes with such substances, for example that are swellable in water but insoluble.
- hydroxyalkyl cellulose for the hydrophilization of polymer membranes can be used.
- Polyvinyl pyrrolidone is also a possible hydrophilizing agent.
- a membrane is considered to be through the liquid is sufficiently wettable to look at if a drop the sample liquid with a volume of 20 ⁇ l at room temperature fully in within less than 20 sec a membrane piece of 15 by 15 mm or larger is sucked up and is held in the membrane or when a task of a Drops of liquid on the large-pored side of an asymmetrical porous membrane to wet the membrane leads in its entire thickness in the task area.
- All wettable membranes can be used according to the invention, to the the substance that is enriched on the fine-pored side should not be adsorbed. Whether a certain membrane substance pair this condition can be easily checked will.
- the substance to be tested is in the solvent solved, with which the enrichment effect is achieved should be, for example in the case of aqueous solutions in water.
- the solution is one or more layers of membrane in question and then checked, whether the concentration of substances in the solution before and different after passing through the membrane is.
- An asymmetrically porous membrane is so in 5 layers in a membrane filter holder (for example from Sartorius, Göttingen, Germany) without glass filter, and so placed on a feeding bottle that the large-pored side of the The membrane points upwards.
- the substance solution to be examined is on the large pore side of the membrane in the filter holder given and by applying a vacuum the membrane sucked.
- the liquid is measured photometrically to its optical density checked and the value with that of the original solution compared.
- Adsorption of the dissolved substance on the membrane has occurred when the optical density of the solution clearly before and after passing through the membrane differs.
- Concentration of the substance in the solution about 1-100 mg / l, Amount of liquid to be sucked through 8 ml, number of Membrane discs 5 pieces, diameter of the membrane discs in Membrane filter holder about 60 mm, thickness of each Membrane disks about 110 to 150 ⁇ m and speed of Aspiration about 0.25 ml / second.
- Substances that are not or not essential (less than 15% according to the test model described above) on the asymmetrical porous membrane are clearly adsorbed on the enriched fine-pored side of the asymmetrically porous membrane.
- a corresponding concentration profile is shown in FIGS. 1, 2 and 3. These figures are in Examples 2 and 3 explained in more detail.
- a concentration profile that shows the behavior shows a substance on an asymmetrically porous membrane, which adsorbs on the membrane and not on the fine-pored Side of the membrane is enriched in Figure 8 shown. This figure is explained in more detail in Example 10.
- a membrane-wetting solution of the substance brought into contact with the asymmetrically porous membrane This can be done by immersing the membrane in the solution or expediently by applying the solution to the membrane respectively.
- the solution to the membrane it is Achievement of the enrichment effect regardless of whether the solution on the fine-pored or on the coarse-pored side becomes.
- the method described above for evenly distributed Enrichment of a substance essentially on a Side of a membrane can be used for a carrier-bound process Determination of an analyte can be used.
- a solution of the substance to be determined with an asymmetrical porous membrane that is wettable by the solution contacted and on the membrane from the fine-pored side certainly.
- it is according to the invention necessary that the substance to be determined is not or is not significantly adsorbed on the membrane.
- the solution of the substance to be determined is applied to the large pore Abandoned side of the membrane.
- the substance to be determined can also be found in or on the membrane Reagents or substances in one or more Layers are arranged, released or over the membrane be formed.
- these are carrier-bound Determination procedure test carrier structures can be used, as known from the prior art, however according to the invention, the layer that is measured, be it visually, optically, reflection photometrically etc., an asymmetrical porous membrane is as characterized above.
- the determination method is particularly suitable good for colored analytes. If the substance to be determined itself is not colored, it can be changed by appropriate Reactions as they are known from clinical analysis, be converted into colored substances or in chemical reactions Give rise to the formation of colored reaction products, which are a measure of the analyte to be determined.
- the invention used asymmetrically porous membrane has only a low wet transparency, d. H. the reflectance of the invention particularly membrane should be used advantageously after wetting the solvent of the solution to be examined is greater than 20%, better still be greater than 50%. Also in this Connection has for the investigation of aqueous solutions, how there are body fluids, such as blood, plasma, serum, Urine, etc. are polysulfone membranes such as those BTS membrane from Memtec Timonium, Maryland, USA proven.
- the combination of the filter property is asymmetrically porous Membranes with low wet transparency prove to be special advantageous when examining liquid samples are said to contain colored particulate components. So brings the use according to the invention corresponding asymmetrical porous membranes have great advantages when used in Method for the determination of substances in vehicles Whole blood.
- a sufficiently hydrophilic membrane with an asymmetry factor greater than 10, preferably greater than 100 the Pores on the fine-pored side of the asymmetrically porous membrane are about 0.003 to 3 ⁇ m in size, the red blood cells (Erythrocytes) prevented from going to the fine pored side to reach the membrane.
- the method according to the invention for carrier-bound determination a substance has proven to be particularly advantageous for the determination of hemoglobin or hemoglobin derivatives from whole blood. From the values for the hemoglobin concentration in the blood you can also see the hematocrit, that's the Proportion of cellular components in the volume of blood, conclude.
- Hemoglobin and hemoglobin derivatives such as hemiglobin rhodanide, Hemiglobin cyanide, hemiglobin, oxihemoglobin or alkaline hematin become more hydrophilic when used asymmetrically porous membranes on the fine-pored Very enriched side.
- a test carrier according to the invention for the determination of hemoglobin or contains hemoglobin derivatives as an essential component an asymmetrically porous membrane made with water is wettable, the hemoglobin or hemoglobin derivative to be determined not significantly adsorbed and the one hemolyzing Carries substance or such substance in one Contains layer arranged over the membrane.
- Hemolytic agents are known to the person skilled in the art.
- detergents for the test carrier according to the invention such as anionic, cationic or non-ionic Detergents are used.
- anionic Detergents are sodium nonyl sulfate, sodium dodecyl sulfate, Sodium dodecyl sulfonate, sodium deoxycholate, sodium dioctyl sulfosuccinate (DONS) or sodium diamyl sulfosuccinate (DANS).
- cationic detergents are Cetylpyridinium chloride, cetyldimethylethylammonium bromide or Cetyltrimethylammonium bromide can be used.
- non-ionic Detergents are especially polyoxyethylene ethers known. According to the invention, as a hemolyzing agent Substance or a mixture of several substances used become.
- the test carrier according to the invention can directly use the hemolysis agent wear on the asymmetrically porous membrane or it can in another layer, which is over the large-pored side the asymmetrically porous membrane is located. No additional layer should be used for the hemolysis agent , the hemolysis agent is expediently brought through Impregnation on the asymmetrically porous membrane. It is also conceivable, the hemolysis agent in a spreadable Apply paste to the large pore side of the membrane and to dry there. When using a separate layer a suitable carrier material also with a solution of Hemolysis agent impregnated or with a spreadable Mass of the hemolysis agent are coated.
- the type of Backing material does not matter as long as there is none Disturbing the determination reaction. As a possible disturbance you could look at the adsorption of hemoglobin to the carrier material or disruptive reactions of the Introduce carrier material with hemoglobin or hemoglobin derivatives.
- a glass fiber fleece, for example, has proven suitable proven.
- Buffer substances have been added to the hemolyzing agent and substances which lead to oxidation or complexation of hemoglobin have been shown to be beneficial.
- Buffer substances that come into question here are those that one Set the pH in the range of 2-12, preferably 6-8 can.
- Phosphate buffer (pH 5-8) citrate buffer (pH 2-8), citrate-phosphate-borate buffer (pH 2-12).
- the test vehicle for the determination of hemoglobin is asymmetrical porous membrane on a rigid material such as a plastic sheet arranged so that the test carrier is better and easier to handle and is asymmetrical porous membrane not when performing the test to have to touch with your fingers.
- the asymmetrically porous The membrane is attached to this support so that either the task of the sample to be examined or the determination on the surface of the asymmetrically porous membrane can, which faces the carrier. At the task the sample on the surface facing the support of the asymmetrical porous membrane, this means that the rigid support material must be permeable to the sample.
- There is a hole in the trap and under the trap Hole is attached to the asymmetrically porous membrane so that the sample can be applied to the membrane through the hole can.
- the carrier in optical measuring methods is translucent.
- Another option is there also in the fact that there is a hole in the carrier and the membrane over this hole on the substrate is attached so that the corresponding surface of the asymmetrical porous membrane can be measured.
- test carriers according to the invention for the determination of hemoglobin are shown in Figures 4, 5 and 6.
- Fig. 7 shows a test carrier with which the uniform Distribution of a substance on the fine-pored side an asymmetrically porous membrane can be demonstrated.
- asymmetric porous membrane (3) with a bilateral adhesive tape (2) is attached to the strip (1).
- the asymmetrically porous membrane (3) is attached so that its shows fine-pored side to strip (1).
- Similar test carrier structures are for example from EP-A-0 256 806 or EP-A-0 407 800 known.
- a hemolyzing agent and possibly still other substances such as buffer substance and / or Hemoglobin oxidizing or complexing agents in the asymmetric porous membrane (3).
- Blood (5) is on the large pore Side of the asymmetrically porous membrane (3), the erythrocytes are hemolyzed in the membrane (3) and the released hemoglobin or corresponding hemoglobin derivatives, for example in the presence of oxidizing or complexing substances as additional reagents, in the membrane (3) on the fine-pored side of the asymmetrical porous membrane (3) evenly distributed and enriched.
- the concentration of hemoglobin or the hemoglobin derivatives on the fine-pored side of the asymmetrically porous membrane (3) determined.
- Blood (5) is through the hole (4) on the large-pored side of the given asymmetrically porous membrane (3).
- the measurement is carried out from the side opposite the hole (4) from the fine-pored surface of the membrane (3).
- a test carrier is shown, which over the large pore Surface of the asymmetrically porous membrane (3) a Layer (6) carries with all or part of the for reagents required for the test can be impregnated.
- this layer (6) can be used for hemolysis of the erythrocytes required substances.
- the blood (5) is applied to the layer (6) by these substances dissolved and get into the with the sample liquid Membrane (3).
- the detection reaction is monitored by the fine-pored side of the membrane (3) through the hole (4).
- a test carrier in which a strip (8) of stiff, translucent material with Hot melt adhesive (7) attaches an asymmetrically porous membrane (3), which is attached so that the fine-pored surface the strip (8) faces.
- a layer (6) for example a glass fiber fleece attached that it does not touch the membrane (3) by However, pressure from above can be brought into contact with her can. In the starting position there is therefore a gap (9) between Membrane (3) and layer (6) before. After giving up the liquid Sample on layer (6) the sample stays there, without getting into the membrane (3). The dwell time is freely selectable.
- An asymmetrically porous membrane BTS 25 (from Memtec Timonium, MD, USA) was impregnated with a solution of 1% sodium dodecyl sulfate, 0.1N phosphate buffer pH 7 and 0.7 mmol / l K 3 Fe (CN) 6 .
- the liquid intake was the equivalent of 115 ml / m 2 .
- the liquid-loaded membrane was dried at 50 ° C for 30 minutes. After cooling with liquid nitrogen, the soaked membrane was broken. The cross section was vapor-deposited with carbon and examined for iron in a scanning electron microscope with EDX microanalysis from Cambridge, Nussloch, Germany.
- An asymmetrically porous membrane (BTS 25, Memtec America Corp. Timonium, Maryland, USA) with a width of 28 cm was in a solution of 1 wt .-% sodium dodecyl sulfate, 0.1 N phosphate buffer pH 7 and 0.7 mmol / l Potassium hexacyanoferrate (III) soaked. The liquid intake was about 115 ml / m 2 . The liquid-loaded membrane was dried at 50 ° C. for 30 minutes.
- the dry membrane was cut into 8 mm wide strips using a double-sided adhesive tape on a 420 ⁇ m thick PVC film, which was provided with a 6 mm diameter hole in the area of the membrane application, in such a way that in the area of the hole the Membrane was not covered by the double-sided adhesive tape.
- the orientation of the asymmetrical membrane was chosen so that the fine-pored side was facing the hole (see FIG. 4).
- about 10 ⁇ l of whole blood was applied to the large-pored side of the membrane in the area of the hole.
- the spotted test strip was inserted into a suitable measuring device and measured on the fine-pored side after 44 seconds. Between the sample application and the time of measurement, a uniformly dark color developed on the fine-pored side.
- the test setup did not include any additional measures to distribute the blood on the task side, the results were unexpectedly high.
- test strip construction analogous to example 5 was realized with the difference that the large-pored side of the membrane for Hole showed (see Fig. 5). The blood was abandoned through the hole in the carrier film. This made it a little easier the accuracy of the sample application. was measured from the fine-pored side. The results were comparable with those from example 5.
- An asymmetrically porous membrane (BTS 25) was used in test strips between a clear, transparent, 200 ⁇ m thick Folie (Pokalon, Lonza, Weil am Rhein, Germany) and a Glass fiber fleece (Trapo 83/14, J.C. Binzer, Hatzfeld / Eder, Germany) so that the large-pored side faces the glass fiber fleece showed between the membrane and the glass fiber fleece but no contact took place (see Fig. 7).
- the glass fiber fleece was soaked in hemiglobin cyanide. After done The test strips were soaked in a suitable device Measured by reflection photometry at 567 nm. It was the mechanical contact before the start of the measurement between the soaked fiberglass fleece and the asymmetrical Membrane manufactured. At a hemiglobin cyanide concentration At 7 g / dl, a remission of 32.69% was observed. The coefficient of variation was 1.77%.
- bromothymol turned blue as not on the fine-pored side of an asymmetrically porous membrane enriching substance examined.
- the corresponding color solution was the soaked and dried BTS 25 membrane (from Memtec Timonium, MD, USA) in liquid Paraffin (melting point 56 - 58 ° C, Merck, Darmstadt, Germany) dipped and then drained. This caused the membrane to become thin Paraffin layer, which stabilizes the structure, but the Dye or the membrane itself does not dissolve.
Description
- Fig. 1:
- Diagramm einer rasterelektronischen EDX-Mikroanalyse eines mit Kohlenstoff bedampften Querschnitts durch eine mit K3[Fe(CN)6] getränkte asymmetrisch poröse Membran.
- Fig. 2:
- Darstellung der remissionsphotometrischen Farbintensität über den Querschnitt einer mit Tartrazin getränkten asymmetrisch porösen Membran
- Fig. 3:
- Darstellung der remissionsphotometrischen Farbintensität über den Querschnitt einer mit Indigotin getränkten asymmetrisch porösen Membran.
- Fig. 4-6:
- Querschnitte durch vorteilhafte Ausführungsformen erfindungsgemäßer Testträger.
- Fig. 7:
- Querschnitt durch einen Testträger, mit dem die gleichmäßige Verteilung einer Substanz auf der feinporigen Seite einer asymmetrisch porösen Membran demonstriert wird.
- Fig. 8:
- Darstellung der remissionsphotometrischen Farbintensität über den Querschnitt einer mit Bromthymolblau getränkten asymmetrisch porösen Membran.
Ergebnisse: | |||||||
Farbstoff | Lösemittel | Anreicherung | Extinktionen | Konzentration | % Unterschied | ||
Vor | Nach | Vor | Nach | ||||
Filtration in % | Filtration in mg/l | ||||||
Indigotin | Wasser | + | 0,055 | 0,050 | 1 | 0,9 | -8,78 |
Toluidin blau | Ethanol | + | 1,124 | 1,08 | 20 | 19,22 | -3,9 |
Wasser | - | 0,47 | 0,392 | 20 | 16,68 | 1 -16,6 | |
Rhodamin B | Ethanol | + | 0,329 | 0,327 | 1,25 | 1,2 | -0,8 |
Coomassie blue | Ethanol | + | 0,68 | 0,682 | 17,5 | 17,55 | +0,2 |
Tartrazin | Wasser | + | 0,242 | 0,241 | 50 | 49,79 | -0,4 |
Safranin | Ethanol | + | 0,79 | 0,79 | 20 | 20 | 0,0 |
Wasser | - | 1,59 | 1,33 | 20 | 16,73 | -16,35 | |
Acid green | Ethanol | + | 0,824 | 0,821 | 80 | 79,71 | -0,36 |
Bromthymolblau | Puffer pH 9 | - | 0,289 | 0,163 | 8 | 4,51 | -43,6 |
Kaliumhexacyanoferrat (III) | 0,1 N phosphatpuffer pH 3 | + | 0,383 | 0,382 | 2000 | 1995,3 | -0,23 |
Claims (12)
- Verwendung einer asymmetrisch porösen Membran zur gleichmäßig verteilten Anreicherung einer Substanz, die nicht oder nicht wesentlich an der Membran adsorbiert wird, in einer Membran-benetzenden Lösung auf der feinporigen Seite der Membran, wobei unter Membran-benetzend verstanden wird, daß die Zeit, die zum vollständigen Einsaugen eines Tropfens der Lösung mit einem Volumen von 20 µl, der auf ein 15×15 mm2 großes Membranstück aufgegeben wird, benötigt wird, sowohl bei Aufgabe auf die grobporige als auch bei Aufgabe auf die feinporige Seite der Membran weniger als 20 s beträgt, und wobei unter nicht oder nicht wesentlich an der Membran adsorbiert verstanden wird, daß nach dem Durchsaugen von 8 ml einer Lösung der Substanz durch einen Stapel aus fünf Membranscheiben der asymmetrisch porösen Membran, wobei die Membranscheiben einen Durchmesser von 60 mm besitzen und die Lösung der Substanz auf die grobporige Seite der asymmetrisch porösen Membran aufgebracht wird, die Konzentration der Substanz im Filtrat verglichen mit der Konzentration der Substanz in der Ausgangslösung um weniger als 15 % abnimmt.
- Verwendung gemäß Anspruch 1, dadurch gekennzeichnet, daß der Asymmetriefaktor der asymmetrisch porösen Membran größer als 10 ist.
- Verfahren zur trägergebundenen Bestimmung einer Substanz in einer flüssigen Probe, bei dem eine Lösung der zu bestimmenden Substanz mit einer asymmetrisch porösen Membran kontaktiert oder die zu bestimmende Substanz in der Probe durch eine oder mehrere auf der Membran oder auf einer der Membran vorgelagerten Schicht vorliegende Stoffe freigesetzt oder gebildet wird und auf der Membran von der feinporigen Seite her bestimmt wird, wobei die zu bestimmende Substanz in der Membran-benetzenden Lösung nicht oder nicht wesentlich an der Membran adsorbiert wird und auf der feinporigen Seite der Membran gleichmäßig angereichert wird, wobei unter Membran-benetzend verstanden wird, daß die Zeit, die zum vollständigen Einsaugen eines Tropfens der Lösung mit einem Volumen von 20 µl, der auf ein 15×15 mm2 großes Membranstück aufgegeben wird, benötigt wird, sowohl bei Aufgabe auf die grobporige als auch bei Aufgabe auf die feinporige Seite der Membran weniger als 20 s beträgt, und wobei unter nicht oder nicht wesentlich an der Membran adsorbiert verstanden wird, daß nach dem Durchsaugen von 8 ml einer Lösung der Substanz durch einen Stapel aus fünf Membranscheiben der asymmetrisch porösen Membran, wobei die Membranscheiben einen Durchmesser von 60 mm besitzen und die Lösung der Substanz auf die grobporige Seite der asymmetrisch porösen Membran aufgebracht wird, die Konzentration der Substanz im Filtrat verglichen mit der Konzentration der Substanz in der Ausgangslösung um weniger als 15 % abnimmt.
- Verfahren gemäß Anspruch 3, dadurch gekennzeichnet, daß die asymmetrisch poröse Membran einen Asymmetriefaktor größer als 10 besitzt.
- Verfahren gemäß Anspruch 3 oder 4, dadurch gekennzeichnet, daß die Porengröße auf der feinporigen Seite der asymmetrisch porösen Membran etwa 0.003 bis 3 µm beträgt.
- Verfahren gemäß einem der Ansprüche 3 bis 5, dadurch gekennzeichnet, daß die asymmetrisch poröse Membran nach Benetzung durch das Lösungsmittel der zu untersuchenden flüssigen Probe noch mehr als 20% einer Meßstrahlung reflektiert.
- Verfahren gemäß einem der Ansprüche 3 bis 6, dadurch gekennzeichnet, daß die zu bestimmende Substanz Hämoglobin oder ein Hämoglobinderivat ist.
- Testträger zur Bestimmung einer Substanz in einer flüssigen Probe, wobei der Testträger eine asymmetrisch poröse Membran enthält, dadurch gekennzeichnet, daß die Substanz Hämoglobin ist, welches in der Membran-benetzenden wässrigen Lösung nicht oder nicht wesentlich an die Membran adsorbiert wird, auf der feinporigen Seite der Membran gleichmäßig verteilt angereichert wird und von der Feinporigen Seite her bestimmt werden kann, wobei unter Membran-benetzend verstanden wird, daß die Zeit, die zum vollständigen Einsaugen eines Tropfens der Lösung mit einem Volumen von 20 µl, der auf ein 15×15 mm2 großes Membranstück aufgegeben wird, benötigt wird, sowohl bei Aufgabe auf die grobporige als auch bei Aufgabe auf die feinporige Seite der Membran weniger als 20 s beträgt, und wobei unter nicht oder nicht wesentlich an der Membran adsorbiert verstanden wird, daß nach dem Durchsaugen von 8 ml einer Lösung der Substanz durch einen Stapel aus fünf Membranscheiben der asymmetrisch porösen Membran, wobei die Membranscheiben einen Durchmesser von 60 mm besitzen und die Lösung der Substanz auf die grobporige Seite der asymmetrisch porösen Membran aufgebracht wird, die Konzentration der Substanz im Filtrat verglichen mit der Konzentration der Substanz in der Ausgangslösung um weniger als 15 % abnimmt, und wobei die Membran selbst eine hämolysierende Substanz trägt oder eine solche Substanz in einer vorgelagerten Schicht enthält.
- Testträger gemäß Anspruch 8, dadurch gekennzeichnet, daß die asymmetrisch poröse Membran zusätzlich eine Substanz trägt, die zur Oxidation oder Komplexierung freien Hämoglobins führt.
- Testträger gemäß einem der Ansprüche 8 bis 9 dadurch gekennzeichnet, daß die asymmetrisch poröse Membran auf einem festen Material so befestigt ist, daß die Aufgabe der zu bestimmenden Substanz in der Probe oder die Bestimmung der Substanz in der Probe auf der Seite der asymmetrisch porösen Membran erfolgt, die dem festen Material zugewandt ist.
- Testträger gemäß Anspruch 10, dadurch gekennzeichnet, daß das feste Material durchscheinend ist.
- Testträger gemäß Anspruch 10, dadurch gekennzeichnet, daß das feste Material ein Loch enthält, über dem die asymmetrisch poröse Membran befestigt ist.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4212280A DE4212280A1 (de) | 1992-04-11 | 1992-04-11 | Asymmetrisch poröse Membranen |
DE4212280 | 1992-04-11 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0586789A2 EP0586789A2 (de) | 1994-03-16 |
EP0586789A3 EP0586789A3 (en) | 1994-07-27 |
EP0586789B1 true EP0586789B1 (de) | 1999-11-24 |
Family
ID=6456672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP93105630A Expired - Lifetime EP0586789B1 (de) | 1992-04-11 | 1993-04-06 | Gleichmässig verteilte Anreicherung einer in Lösung vorliegenden Substanz auf der feinporigen Seite einer asymmetrisch porösen Membran |
Country Status (6)
Country | Link |
---|---|
US (1) | US6287867B1 (de) |
EP (1) | EP0586789B1 (de) |
JP (1) | JP2815773B2 (de) |
AT (1) | ATE186982T1 (de) |
DE (2) | DE4212280A1 (de) |
ES (1) | ES2141739T3 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU692845B2 (en) * | 1994-03-04 | 1998-06-18 | Memtec America Corporation | Large pore synthetic polymer membranes |
US6638415B1 (en) | 1995-11-16 | 2003-10-28 | Lifescan, Inc. | Antioxidant sensor |
US6200532B1 (en) * | 1998-11-20 | 2001-03-13 | Akzo Nobel Nv | Devices and method for performing blood coagulation assays by piezoelectric sensing |
SE518539C2 (sv) * | 2000-06-28 | 2002-10-22 | Migrata U K Ltd | Sätt och kyvett för kvantitativ hemoglobinbestämning i outspätt helblod |
AU2000267325A1 (en) * | 2000-08-28 | 2002-03-13 | Sapporo Immuno Diagnostic Laboratory | Simple implement for collecting/recovering liquid sample |
CN100437114C (zh) | 2001-04-12 | 2008-11-26 | 爱科来株式会社 | 样品分析装置 |
US20060062688A1 (en) * | 2004-02-03 | 2006-03-23 | Polymer Technology Systems, Inc. | Bodily fluid analysis system |
US7625721B2 (en) | 2004-02-03 | 2009-12-01 | Polymer Technology Systems, Inc. | Non-precipitating bodily fluid analysis system |
US8465696B2 (en) * | 2004-02-03 | 2013-06-18 | Polymer Technology Systems, Inc. | Dry test strip with controlled flow and method of manufacturing same |
WO2006023679A1 (en) * | 2004-08-17 | 2006-03-02 | Polymer Technology Systems, Inc. | Apparatus and method for manufacturing bodily fluid test strip |
TWI460007B (zh) | 2009-04-13 | 2014-11-11 | Entegris Inc | 多孔複合薄膜 |
EP3078956A4 (de) * | 2013-12-03 | 2017-06-28 | The University of Tokyo | Trenneinheit, trennverfahren, flüssigkeitsvorrichtung und kompositflüssigkeitsvorrichtung und -kit |
DE102018004521A1 (de) * | 2018-06-07 | 2019-12-12 | Sartorius Stedim Biotech Gmbh | Serielle Anordnung mit mehreren Lagen asymmetrischer Filtermedien, Herstellungsverfahren, Filtrationseinheit, Verwendung der Anordnung und Charakterisierungsverfahren |
CN116324407A (zh) * | 2021-10-19 | 2023-06-23 | 谷歌有限责任公司 | 用于确定血红蛋白浓度的竖直流动测定设备和方法 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3607093A (en) | 1968-02-15 | 1971-09-21 | Schering Corp | Devices for testing biological liquids |
NO770196L (no) * | 1976-01-22 | 1977-07-25 | Wellcome Found | Kjemiske pr¦vesystemer. |
DE2729924C2 (de) * | 1977-07-02 | 1985-06-05 | Boehringer Mannheim Gmbh, 6800 Mannheim | Vorrichtung zur Dosierung von Stuhlmengen auf Reagenzpapieren |
JPS5917386B2 (ja) * | 1979-03-23 | 1984-04-20 | テルモ株式会社 | 血液分離方法および装置 |
US4307188A (en) * | 1979-09-06 | 1981-12-22 | Miles Laboratories, Inc. | Precursor indicator compositions |
US4323536A (en) * | 1980-02-06 | 1982-04-06 | Eastman Kodak Company | Multi-analyte test device |
US4629563B1 (en) * | 1980-03-14 | 1997-06-03 | Memtec North America | Asymmetric membranes |
US4774039A (en) | 1980-03-14 | 1988-09-27 | Brunswick Corporation | Dispersing casting of integral skinned highly asymmetric polymer membranes |
US4427416A (en) * | 1980-10-10 | 1984-01-24 | Duke University | Processes for extracting oxygen from fluids using immobilized hemoglobin |
JPS5767860A (en) * | 1980-10-15 | 1982-04-24 | Fuji Photo Film Co Ltd | Material for multilayer analysis |
DE3134611A1 (de) * | 1981-09-01 | 1983-03-10 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur durchfuehrung analytischer bestimmungen und hierfuer geeignetes mittel |
US4558032A (en) * | 1981-12-31 | 1985-12-10 | Neomed Inc. | Synthetic whole blood substitute and a method of making the same |
US4413074A (en) * | 1982-01-25 | 1983-11-01 | Brunswick Corporation | Hydrophilic surfaces and process for making the same |
DE3323973A1 (de) * | 1983-07-02 | 1985-01-03 | Boehringer Mannheim Gmbh, 6800 Mannheim | Erythrozyten-rueckhaltesubstrate |
DE3407359A1 (de) * | 1984-02-29 | 1985-08-29 | Bayer Ag, 5090 Leverkusen | Testvorrichtung und methode zum nachweis einer komponente einer fluessigen probe |
US4806311A (en) * | 1985-08-28 | 1989-02-21 | Miles Inc. | Multizone analytical element having labeled reagent concentration zone |
US4935346A (en) | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
US4774192A (en) * | 1987-01-28 | 1988-09-27 | Technimed Corporation | A dry reagent delivery system with membrane having porosity gradient |
JPS63196849A (ja) * | 1987-02-12 | 1988-08-15 | Fuji Photo Film Co Ltd | 一体型多層分析要素 |
US4912034A (en) * | 1987-09-21 | 1990-03-27 | Biogenex Laboratories | Immunoassay test device and method |
DE3735684A1 (de) * | 1987-10-22 | 1989-05-03 | Boehringer Mannheim Gmbh | Immunreaktives traegermaterial und verfahren zu seiner herstellung |
GB2213932A (en) * | 1987-12-15 | 1989-08-23 | Pall Corp | Dipstick immunodiagnostic device |
US5114673A (en) * | 1988-01-21 | 1992-05-19 | Boehringer Mannheim Corporaton | Apparatus for determination of a component in a sample |
NL8800796A (nl) | 1988-03-29 | 1989-10-16 | X Flow Bv | Werkwijze voor de chemische analyse van bestanddelen van een lichaamsvloeistof, alsmede een testinrichting en testpakket voor een dergelijke analyse. |
JP2644331B2 (ja) | 1988-06-09 | 1997-08-25 | アプライズ・インコーポレーテッド | 液体の化学的分析のための改良可処分装置 |
DE3826057A1 (de) * | 1988-07-30 | 1990-02-01 | Boehringer Mannheim Gmbh | Testtraeger zur analytischen bestimmung eines bestandteils einer fluessigen probe |
JPH0721455B2 (ja) * | 1988-12-01 | 1995-03-08 | 株式会社京都第一科学 | 液体試料中の特定成分を分析するための用具および方法 |
US5234812A (en) * | 1988-12-08 | 1993-08-10 | Boehringer Mannheim Corporation | Method for sequential determination of an analyte in a fluid sample using a third receptor |
DE69014958T2 (de) | 1989-04-07 | 1995-07-06 | Ube Industries | Pervaporationsverfahren zur selektiven Trennung von Wasser aus einer organische Verbindungen enthaltenden wässerigen Lösung mittels einer asymmetrischen Membran aus einem aromatischen Polyimid. |
JP2782769B2 (ja) * | 1989-04-07 | 1998-08-06 | 宇部興産株式会社 | 有機物水溶液の浸透気化分離方法 |
US5234813A (en) * | 1989-05-17 | 1993-08-10 | Actimed Laboratories, Inc. | Method and device for metering of fluid samples and detection of analytes therein |
DE3922495A1 (de) * | 1989-07-08 | 1991-01-17 | Miles Inc | Analyseverfahren fuer substanzen aus biologischen fluessigkeiten, insbesondere vollblut |
DE4015157A1 (de) | 1990-05-11 | 1991-11-14 | Miles Inc | Asymetrische sandwich-membranen fuer diagnose-teststreifen |
DE4015589A1 (de) | 1990-05-15 | 1991-11-21 | Boehringer Mannheim Gmbh | Vorrichtung und deren verwendung zur abtrennung von plasma aus vollblut |
US5187100A (en) * | 1990-05-29 | 1993-02-16 | Lifescan, Inc. | Dispersion to limit penetration of aqueous solutions into a membrane |
JP2547664B2 (ja) * | 1990-10-20 | 1996-10-23 | 富士写真フイルム株式会社 | 鉄イオン分析用乾式分析要素 |
-
1992
- 1992-04-11 DE DE4212280A patent/DE4212280A1/de not_active Ceased
-
1993
- 1993-04-06 ES ES93105630T patent/ES2141739T3/es not_active Expired - Lifetime
- 1993-04-06 DE DE59309881T patent/DE59309881D1/de not_active Expired - Fee Related
- 1993-04-06 EP EP93105630A patent/EP0586789B1/de not_active Expired - Lifetime
- 1993-04-06 AT AT93105630T patent/ATE186982T1/de not_active IP Right Cessation
- 1993-04-09 JP JP5083655A patent/JP2815773B2/ja not_active Expired - Fee Related
-
1994
- 1994-08-26 US US08/296,855 patent/US6287867B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH0772145A (ja) | 1995-03-17 |
EP0586789A3 (en) | 1994-07-27 |
DE59309881D1 (de) | 1999-12-30 |
JP2815773B2 (ja) | 1998-10-27 |
ATE186982T1 (de) | 1999-12-15 |
ES2141739T3 (es) | 2000-04-01 |
DE4212280A1 (de) | 1993-10-14 |
US6287867B1 (en) | 2001-09-11 |
EP0586789A2 (de) | 1994-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE19781288B4 (de) | Opake Reaktionsmatrix zur Analyse von Vollblut | |
DE3100156C2 (de) | ||
DE2332760C3 (de) | Material für die quantitative spektrophotometrische Analyse einer Flüssigkeit | |
EP0133895B1 (de) | Erythrozyten-Rückhaltesubstrate | |
EP0457183B1 (de) | Vorrichtung und deren Verwendung zur Abtrennung von Plasma aus Vollblut | |
EP0821234B1 (de) | Diagnostischer Testträger mit mehrschichtigem Testfeld und Verfahren zur Bestimmung von Analyten mit dessen Hilfe | |
EP0586789B1 (de) | Gleichmässig verteilte Anreicherung einer in Lösung vorliegenden Substanz auf der feinporigen Seite einer asymmetrisch porösen Membran | |
DE3329728C2 (de) | ||
DE3029579C2 (de) | Verfahren und Mittel zur Abtrennung von Plasma oder Serum aus Vollblut | |
EP0154839B1 (de) | Testvorrichtung und Methode zum Nachweis einer Komponente einer flüssigen Probe | |
EP0175990A2 (de) | Membran für Reagenzträgerschichten, Verfahren zu deren Herstellung, sowie deren Verwendung in analytischen Mitteln und Analysenverfahren | |
DE2717817A1 (de) | Analytisches element | |
DE2922958A1 (de) | Mehrschichtiges integrales element zur chemischen analyse von blut | |
DE2532918C3 (de) | Integrales analytisches Element für die Analyse von Flüssigkeiten | |
DE2801476A1 (de) | Kolorimetrisches verfahren fuer die bestimmung von bilirubin | |
DE3809523A1 (de) | Verfahren zur herstellung von poroesen membranen, die damit hergestellten membranen und deren verwendung als traegermatrices in teststreifen | |
DE3506365C2 (de) | ||
EP0995994B1 (de) | Funktionsschichten mit hoher Präzision, Verfahren zu ihrer Herstellung und Teststreifen enthaltend diese Funktionsschichten | |
DE3215983C2 (de) | ||
EP0995992B1 (de) | Spreitschichten, Netzmittel zu ihrer Herstellung und deren Verwendung in Teststreifen | |
EP0575364B1 (de) | Testträger zur bestimmung eines analyten aus vollblut | |
DE3202667A1 (de) | Analyseneinheit | |
EP1531331B1 (de) | Verfahren zur Bestimmung von glycosyliertem Hämoglobin mittels einer Extraktionsschicht | |
EP0457123B1 (de) | Testträger für die analytische Bestimmung eines Bestandteils einer Probenflüssigkeit | |
DE3433563A1 (de) | Vorrichtung aus polymeren mit membranstruktur und eingelagerten feststoffpartikeln |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19930406 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE |
|
17Q | First examination report despatched |
Effective date: 19960902 |
|
RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ROCHE DIAGNOSTICS GMBH |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY Effective date: 19991124 Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19991124 |
|
REF | Corresponds to: |
Ref document number: 186982 Country of ref document: AT Date of ref document: 19991215 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REF | Corresponds to: |
Ref document number: 59309881 Country of ref document: DE Date of ref document: 19991230 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: GERMAN |
|
ITF | It: translation for a ep patent filed |
Owner name: BIANCHETTI - BRACCO - MINOJA S.R.L. |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20000224 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20000224 |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2141739 Country of ref document: ES Kind code of ref document: T3 |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20000310 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20000406 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20000406 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20000430 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20000430 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20000430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20000719 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FD4D |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
BERE | Be: lapsed |
Owner name: ROCHE DIAGNOSTICS G.M.B.H. Effective date: 20000430 |
|
26N | No opposition filed | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20030402 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20030408 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20030417 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20030429 Year of fee payment: 11 Ref country code: ES Payment date: 20030429 Year of fee payment: 11 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040406 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20040407 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20041101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20041103 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20041231 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20041101 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20050406 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20040407 |